Saturday, August 14, 2010

Carboplatin Treatment for Mesothelioma


Image : http://www.flickr.com


Carboplatin was initially discovered and researched in March 1994 by the London Institute of Cancer Research, it gained Food and Drug Administration. In 2004 a generic version of the drug became available.

Carboplatin is a modification of Cisplatin drug but with less severe side effects than most chemotherapy medications. It is sometimes used for mesothelioma treatment and is commonly administered for treating lung, ovarian, neck and head cancers.

This medicine binds with DNA and makes the cells function abnormally until in the end, they die. It is an out-patient medication carried out in a hospital or cancer treatment center.  Some patients might need to stay in a hospital overnight if the doctor deems necessary for more frequent sessions or a combination with other drugs.

Side effects of carboplatin may include less severe degrees of constipation, impaired hearing or vision, loss of appetite, loss of hair, mild fatigue, nausea, stomach pain and vomiting.

Patients who are under Carboplatin treatment may become more vulnerable to infection because of the reduction of the functions of the immune system. They are therefore advised to steer clear of sick individuals, even colds lest they contract sickness that may complicate their situation.

Kidney damage is another side effect of Carboplatin. Patient may experience difficulty or pain during urination or the presence of blood in the urine.

Any occurrence of these side effects, no matter how insignificant in terms of degree, must be communicated to your physician. A proper documentation will also be very helpful for future reference, as well as to keep you organized while under treatment.

No comments:

Post a Comment